Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells

Luis Galan Palma, PhD, Gayathri M Kartha, Maria Maqueda, Mercedes Barrero, Eric Canton, Arnau Iglesias, Jessica Gonzalez Miranda, Patricia Herrero Molinero, Raul Torres-Ruíz, Bernhard Payer, Clara Bueno, Pablo Menendez, Lluis Espinosa, Anna Bigas

Blood blood.2024027742.

https://doi.org/10.1182/blood.2024027742

Published: 2025

Includes: Supplemental data

Journal Articles

Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma

Smith Giri, Binod Dhakal, Natalie S Callander, Eva Medvedova, Kelly Godby, Bhagirathbhai Dholaria, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca Silbermann, Luciano J. Costa

Blood blood.2024027674.

https://doi.org/10.1182/blood.2024027674

Published: 2025

Includes: Supplemental data

Journal Articles

MRD-Guided Sequential Therapy for Deep Response in Newly Diagnosed Multiple Myeloma (NDMM)- Master-2 Trial

Blood (2024) 144 (Supplement 1): 2000.1.

https://doi.org/10.1182/blood-2024-200210

Published: 2024

Journal Articles

Implications of MRD Progression in Newly Diagnosed Multiple Myeloma (NDMM) Treated with Quadruplet Therapy and Autologous Stem Cell Transplantation

Luciano J. Costa, Eva Medvedova, Binod Dhakal, Bhagirathbhai Dholaria, Smith Giri, Saurabh Chhabra, Susan Bal, Kelly Godby, Gayathri Ravi, Rebecca W. Silbermann, Natalie Callander

Blood (2024) 144 (Supplement 1): 363.

https://doi.org/10.1182/blood-2024-201914

Published: 2024

Journal Articles

Optimal MRD-Based Endpoint in the Setting of Upfront Quadruplets (QUADs) to Support Response-Adapted Treatment Cessation in Newly Diagnosed Multiple Myeloma (NDMM)

Smith Giri, Binod Dhakal, Natalie Callander, Eva Medvedova, Kelly Godby, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca W. Silbermann, Luciano J. Costa

Blood (2024) 144 (Supplement 1): 257.

https://doi.org/10.1182/blood-2024-205611

Published: 2024

Journal Articles

Phase 2 Trial of Siltuximab for the Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR-T Cell Therapy

Mayur S. Narkhede, Antonio Di Stasi, Lauren Kelly Shea, Susan Bal, Gayathri Ravi, Gaurav Goyal, Pamela Hardwick, Smith Giri, Donna Salzman, Ravi Bhatia, Luciano J. Costa, Amitkumar Mehta

Blood (2024) 144 (Supplement 1): 3449.

https://doi.org/10.1182/blood-2024-205205

Published: 2024

Journal Articles

Clinical Characteristics and Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Study from a Tertiary Care Centre in South India

Gohul Gopi Jalajakumari, Manoj Unni, Vidya Jha, Bindhu Paul-Prasanth, Amal Nandu, Rema Ganapathy, Monisha Harimadhavan, Gayathri Sajeevan, Akhila M, Georg Gutjahr, Anandkrishnan N, Syamaprasad Vinayakumar, Ullas Mony, Neeraj Sidharthan

Blood (2024) 144 (Supplement 1): 3708.

https://doi.org/10.1182/blood-2024-211052

Published: 2024

Journal Articles

Factors Associated with Post-Transplant Complications Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Apoorva Doshi, Gayathri Ravi, Susan Bal, Supriya Maheshwari, Kelly Godby, Luciano J. Costa, Joshua Richman, Grant Williams, Smita Bhatia, Smith Giri

Blood (2024) 144 (Supplement 1): 5145.

https://doi.org/10.1182/blood-2024-201737

Published: 2024

Journal Articles

Combination Regimens in MM Post Autologous Hematopoietic Cell Transplantation (AHCT) to Eliminate MRD Utilizing Iberdomide (COMMANDER): Results of Dose-Finding Component of a Phase 1b/2 Trial

Natalie Callander, Gayathri Ravi, Rebecca W. Silbermann, Zhubin J. Gahvari, Eva Medvedova, Bhagirathbhai Dholaria, Naresh Bumma, Doris K. Hansen, Everette M Colquette, Pamela Hardwick, Luciano J. Costa

Blood (2024) 144 (Supplement 1): 3365.

https://doi.org/10.1182/blood-2024-210652

Published: 2024

Journal Articles

Feasibility and Accuracy of Bioelectric Impedance Analysis in Estimating Skeletal Muscle Mass in Older Adults with Multiple Myeloma

Apoorva Doshi, Abigail Tucker, Gayathri Ravi, Susan Bal, Kelly Godby, William Evans, Mahalakshmi Shubha Shankaran, Luciano J. Costa, Grant Williams, Smita Bhatia, Smith Giri

Blood (2024) 144 (Supplement 1): 6963.

https://doi.org/10.1182/blood-2024-201688

Published: 2024

Journal Articles

Pharmacodynamic Profiles of Patients (Pts) with Newly Diagnosed (ND) Vs Relapsed/Refractory Multiple Myeloma (RRMM) Who Received Teclistamab (Tec) or Talquetamab (Tal) Plus Daratumumab (Dara) and Lenalidomide (Len) in the Phase 1b Majestec-2 and Monumental-2 Studies

Blood (2024) 144 (Supplement 1): 4653.

https://doi.org/10.1182/blood-2024-200333

Published: 2024

Journal Articles

Establishing a CAR-T Cell Therapy Centre in a Resource Limited Setting: Barriers and Early Outcomes

Shreya Agrawal, Gopal Nandkishor Sinhal, Manoj Unni, Monisha Harimadhavan, Rema Ganapathy, Nikhil Krishna Haridas, Syamaprasad Vinayakumar, Chitra Sreenaryanan, Georg Gutjahr, Gayathri Sajeevan, Ullas Mony, Neeraj Sidharthan

Blood (2024) 144 (Supplement 1): 7590.

https://doi.org/10.1182/blood-2024-210827

Published: 2024

Journal Articles

Real World Evidence on Patient Reported Outcomes Among Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Regimens in Frontline (1L)

Smith Giri, Liton Francisco, Nicole Rafalko, Niodita Gupta-Werner, Joshua Richman, Smita Bhatia, Kelly Godby, Gayathri Ravi, Susan Bal, Marjohn Armoon, Rohan Medhekar, Luciano J. Costa

Blood (2024) 144 (Supplement 1): 5151.

https://doi.org/10.1182/blood-2024-203431

Published: 2024

Journal Articles

Decisional Regret Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Apoorva Doshi, Gayathri Ravi, Kelly Godby, Susan Bal, Victoria Badia, Luciano J. Costa, Grant Williams, Smita Bhatia, Smith Giri

Blood (2024) 144 (Supplement 1): 3767.

https://doi.org/10.1182/blood-2024-201735

Published: 2024

Journal Articles

Functional Decline Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoetic Stem Cell Transplantation

Apoorva Doshi, Abigail Tucker, Clare Ubarsax, Gayathri Ravi, Grant Williams, Smith Giri

Blood (2024) 144 (Supplement 1): 2396.

https://doi.org/10.1182/blood-2024-212176

Published: 2024

Journal Articles

Longitudinal Trajectories of Patient-Reported Outcomes Among Older Adults with Multiple Myeloma (MM) Following Autologous Stem Cell Transplantation (ASCT)

Victoria Badia, Apoorva Doshi, Gayathri Ravi, Susan Bal, Kelly Godby, Donna Murdaugh, Luciano J. Costa, Grant Williams, Smita Bhatia, Smith Giri

Blood (2024) 144 (Supplement 1): 2387.

https://doi.org/10.1182/blood-2024-205712

Published: 2024

Journal Articles

Health Outcome Preferences Among Older Adults with Multiple Myeloma Undergoing Systemic Therapy

Miguel Arias, Clare Ubersax, Abigail Tucker, Susan Bal, Gayathri Ravi, Kelly Godby, Luciano Costa, Grant Williams, Sadeep Shrestha, Smita Bhatia, Smith Giri

Blood (2023) 142 (Supplement 1): 2400.

https://doi.org/10.1182/blood-2023-189623

Published: 2023

Journal Articles

Late Effects of Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma. Swiss Cohort Analysis 1997-2021

Ekaterina Rebmann, Alexander von Werdt, Arnaud Künzi, Nathan Wolfensberger, Helen Baldomero, Michael Medinger, Jakob R. Passweg, Gayathri Nair, Stavroula Masouridi-Levrat, Yves Chalandon, Alicia Rovó

Blood (2023) 142 (Supplement 1): 7038.

https://doi.org/10.1182/blood-2023-190579

Published: 2023

Journal Articles

Outcomes of Patients with Newly Diagnosed Multiple Myeloma Experiencing Treatment Failure after Upfront Quadruplet Therapy and Autologous Stem Cell Transplantationgayathri Ravi 1 , Susan Bal 1 , Kelly Godby 1 , Smith Giri 1 , Clare Ubersax 1 , Abigail Tucker 1 , Luciano J Costa 1

Gayathri Ravi, Susan Bal, Kelly Godby, Smith Giri, Clare Ubersax, Abigail Tucker, Luciano Costa

Blood (2023) 142 (Supplement 1): 1989.

https://doi.org/10.1182/blood-2023-188272

Published: 2023

Journal Articles

Neurocognitive Performance Changes with Chimeric Antigen Receptor T-Cell Therapy in Patients with Hematologic Malignancies

Smith Giri, Smith Giri, Clare Ubersax, Abigail Tucker, Susan Bal, Kelly Godby, Luciano Costa, Smita Bhatia, Grant Williams, Gayathri Ravi, Mayur Narkhede, Donna Murdaugh

Blood (2023) 142 (Supplement 1): 5165.

https://doi.org/10.1182/blood-2023-189872

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells

Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma

MRD-Guided Sequential Therapy for Deep Response in Newly Diagnosed Multiple Myeloma (NDMM)- Master-2 Trial

Implications of MRD Progression in Newly Diagnosed Multiple Myeloma (NDMM) Treated with Quadruplet Therapy and Autologous Stem Cell Transplantation

Optimal MRD-Based Endpoint in the Setting of Upfront Quadruplets (QUADs) to Support Response-Adapted Treatment Cessation in Newly Diagnosed Multiple Myeloma (NDMM)

Phase 2 Trial of Siltuximab for the Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR-T Cell Therapy

Clinical Characteristics and Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Study from a Tertiary Care Centre in South India

Factors Associated with Post-Transplant Complications Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Combination Regimens in MM Post Autologous Hematopoietic Cell Transplantation (AHCT) to Eliminate MRD Utilizing Iberdomide (COMMANDER): Results of Dose-Finding Component of a Phase 1b/2 Trial

Feasibility and Accuracy of Bioelectric Impedance Analysis in Estimating Skeletal Muscle Mass in Older Adults with Multiple Myeloma

Pharmacodynamic Profiles of Patients (Pts) with Newly Diagnosed (ND) Vs Relapsed/Refractory Multiple Myeloma (RRMM) Who Received Teclistamab (Tec) or Talquetamab (Tal) Plus Daratumumab (Dara) and Lenalidomide (Len) in the Phase 1b Majestec-2 and Monumental-2 Studies

Establishing a CAR-T Cell Therapy Centre in a Resource Limited Setting: Barriers and Early Outcomes

Real World Evidence on Patient Reported Outcomes Among Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Regimens in Frontline (1L)

Decisional Regret Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Functional Decline Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoetic Stem Cell Transplantation

Longitudinal Trajectories of Patient-Reported Outcomes Among Older Adults with Multiple Myeloma (MM) Following Autologous Stem Cell Transplantation (ASCT)

Health Outcome Preferences Among Older Adults with Multiple Myeloma Undergoing Systemic Therapy

Late Effects of Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma. Swiss Cohort Analysis 1997-2021

Outcomes of Patients with Newly Diagnosed Multiple Myeloma Experiencing Treatment Failure after Upfront Quadruplet Therapy and Autologous Stem Cell Transplantationgayathri Ravi 1 , Susan Bal 1 , Kelly Godby 1 , Smith Giri 1 , Clare Ubersax 1 , Abigail Tucker 1 , Luciano J Costa 1

Neurocognitive Performance Changes with Chimeric Antigen Receptor T-Cell Therapy in Patients with Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only